NDAORALSUSPENSION
Approved
Apr 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Children's Advil Cold is a fixed-dose combination of ibuprofen (NSAID) and pseudoephedrine hydrochloride (decongestant) in oral suspension form for pediatric patients. It is indicated for the temporary relief of cold and flu symptoms including fever, aches, pains, and nasal congestion in children. The ibuprofen reduces inflammation and fever while pseudoephedrine constricts blood vessels to relieve congestion.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), indicating team focus is shifting toward lifecycle extension or transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Children's Advil Cold offers limited career growth given its LOE-approaching status and zero linked job openings. Career opportunities are concentrated in commercial optimization, generic defense, and lifecycle extension rather than innovation or launch activities.
Brand ManagerField Sales Representative
Worked on CHILDREN'S ADVIL COLD at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.